Participation in AMWC Monaco 2026 — Global Launch of NADX³ and AxeniQ™
2026-03-30
본문

Bringing the 2026 launches to the world stage at the leading aesthetic and anti-ageing congress
Monte-Carlo, Monaco — 26–28 March 2026 — Genèse Labs returned to AMWC at the Grimaldi Forum for a second consecutive year, successfully staging the global launch of NADX³ and AxeniQ™. For three days, the booth was crowded with practitioners and distribution partners from around the world.
• Second consecutive participation in AMWC Monaco, following 2025
• Global launch of NADX³ and AxeniQ™
• In a European market that favours natural results, Proluma™ PDLLA and PLLA remained in high demand
• NADX³ in the spotlight amid the longevity trend — a busy booth throughout the show
A Second Year in Monaco, New Categories
Having presented the complete Proluma™ line at its first AMWC in 2025, Genèse Labs returned to Monaco a year later with two new categories. As the congress where the international medical community first evaluates new products, AMWC was the natural stage for the global debut of NADX³ and AxeniQ™.
What the European Market Wanted
European practitioners favour natural, gradual improvement over excessive volume, and look closely at certification history and scientific evidence. In line with this, the CE-certified collagen biostimulators Proluma™ PDLLA and PLLA remained as popular as ever. With longevity a central theme of this year’s AMWC, NADX³ became the most-enquired-about product at the booth.
A Successful Global Launch
For three days the booth was continuously busy with partner meetings and practitioners seeking consultations, and distribution discussions for both launches opened across Europe, the Middle East and Asia. The momentum that began at KIMES expanded onto the global stage at AMWC Monaco.
“AMWC is where new products first face the judgement of the global medical community. The response we received there gave us great confidence.” — Genèse Labs, Company statement
About Genèse Labs
Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across body contouring, collagen biostimulation, fillers, neuromodulators, and longevity and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including the RG Body Filler line, Proluma™ (PDLLA, PLLA and RH Collagen), Réluma, SofistiCa, AxeniQ™, NADX³, Aqua Feel, MESO PEPTA™, Citrus Bottle™, Exoluma™ (Human, Plant and Exo-PDRN) and Exo-Mask — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.
Contact
For distributor inquiries, collaborations, or product information, please contact:
- PrevParticipation in AMWC Korea 2026 26.06.22
- NextParticipation in KIMES 2026 — Korean Debut of NADX³ and AxeniQ™ 26.03.23




